Form D · Biotechnology
MACROGENICS INC
Rockville, MD · CIK 0001125345
Offering snapshot reported Jan 31, 2011 · SEC filing
- Reported sold
- $12M Offering amount: $12M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 19, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 31, 2011 | Initial | $12,016,500 | No comparison | 3 | SEC filing |
| Oct 7, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jul 29, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 26, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-154617
Source: Form D, filed Jan 31, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Paulo Costa | Director |
| Ken Galbraith | Director |
| Ed Hurwitz | Director |
| James Karrels | Executive |
| Scott Koenig | Director, Executive |
| Arnold Oronsky | Director |
| Paul Sekhri | Director |
| Michael Steinmetz | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1500 East Gude Drive
Rockville, MD, 20850
Rockville, MD, 20850